date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.37890760860986.
The log-likelihood improved by 3.273.
Iteration 2 of at most 500:
Optimizing with step length 0.684510260158137.
The log-likelihood improved by 2.738.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.1198.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.03801.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       6       20     1232     1043      814      350      353      335 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     303      216      143      100       49       24        8        1 
degree16 degree17 
       2        1 
1 
disease_progression 
H-positive risk:  826 873 97 931 457 136 907 403 122 58 126 64 
H-negative risk:  873 826 907 931 403 457 136 97 126 122 64 58 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 3 

clinical_engagement 
diagnosis 
demography 
63 new agents 
2 
disease_progression 
H-positive risk:  826 878 97 931 458 138 904 403 124 55 125 61 
H-negative risk:  878 826 904 931 403 458 138 97 125 124 61 55 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 4 

clinical_engagement 
diagnosis 
demography 
51 new agents 
3 
disease_progression 
H-positive risk:  834 885 99 929 457 137 899 397 124 55 124 60 
H-negative risk:  885 834 899 929 397 457 137 99 124 124 60 55 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 6 

clinical_engagement 
diagnosis 
demography 
44 new agents 
4 
disease_progression 
H-positive risk:  842 891 100 929 458 137 893 392 119 54 125 60 
H-negative risk:  891 842 893 929 392 458 137 100 125 119 60 54 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 7 

clinical_engagement 
diagnosis 
demography 
57 new agents 
5 
disease_progression 
H-positive risk:  847 892 101 932 454 139 893 389 119 54 121 59 
H-negative risk:  892 847 893 932 389 454 139 101 121 119 59 54 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 9 

clinical_engagement 
diagnosis 
demography 
57 new agents 
6 
disease_progression 
H-positive risk:  854 899 101 930 445 139 893 387 118 54 123 57 
H-negative risk:  899 854 893 930 387 445 139 101 123 118 57 54 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 12 1 

clinical_engagement 
diagnosis 
demography 
65 new agents 
7 
disease_progression 
H-positive risk:  862 905 102 930 436 139 894 381 118 53 122 58 
H-negative risk:  905 862 894 930 381 436 139 102 122 118 58 53 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 13 1 

clinical_engagement 
diagnosis 
demography 
70 new agents 
8 
disease_progression 
H-positive risk:  862 907 102 929 437 139 896 378 121 53 121 55 
H-negative risk:  907 862 896 929 378 437 139 102 121 121 55 53 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 14 1 

clinical_engagement 
diagnosis 
demography 
53 new agents 
9 
disease_progression 
H-positive risk:  864 903 102 929 438 139 902 376 119 52 121 55 
H-negative risk:  903 864 902 929 376 438 139 102 121 119 55 52 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 18 1 

clinical_engagement 
diagnosis 
demography 
58 new agents 
10 
disease_progression 
H-positive risk:  867 917 104 924 433 137 899 373 120 51 121 54 
H-negative risk:  917 867 899 924 373 433 137 104 121 120 54 51 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 19 1 

clinical_engagement 
diagnosis 
demography 
68 new agents 
11 
disease_progression 
H-positive risk:  873 927 105 921 430 139 893 367 120 50 122 53 
H-negative risk:  927 873 893 921 367 430 139 105 122 120 53 50 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 25 1 

clinical_engagement 
diagnosis 
demography 
54 new agents 
12 
disease_progression 
H-positive risk:  880 925 107 923 425 139 895 360 120 49 125 52 
H-negative risk:  925 880 895 923 360 425 139 107 125 120 52 49 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 25 1 

clinical_engagement 
diagnosis 
demography 
64 new agents 
13 
disease_progression 
H-positive risk:  821 859 101 996 421 126 944 358 137 49 135 53 
H-negative risk:  859 821 944 996 358 421 126 101 135 137 53 49 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 31 3 

clinical_engagement 
diagnosis 
demography 
196 new agents 
14 
disease_progression 
H-positive risk:  849 885 105 947 455 132 888 377 129 49 134 50 
H-negative risk:  885 849 888 947 377 455 132 105 134 129 50 49 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 37 4 

clinical_engagement 
diagnosis 
demography 
57 new agents 
15 
disease_progression 
H-positive risk:  850 886 106 954 449 134 884 376 129 47 134 51 
H-negative risk:  886 850 884 954 376 449 134 106 134 129 51 47 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 38 4 

clinical_engagement 
diagnosis 
demography 
62 new agents 
16 
disease_progression 
H-positive risk:  857 895 106 954 441 137 876 373 129 44 137 51 
H-negative risk:  895 857 876 954 373 441 137 106 137 129 51 44 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 39 4 

clinical_engagement 
diagnosis 
demography 
69 new agents 
17 
disease_progression 
H-positive risk:  862 896 105 955 433 137 879 370 129 42 140 52 
H-negative risk:  896 862 879 955 370 433 137 105 140 129 52 42 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 46 4 

clinical_engagement 
diagnosis 
demography 
59 new agents 
18 
disease_progression 
H-positive risk:  869 903 105 959 431 137 870 361 132 41 141 51 
H-negative risk:  903 869 870 959 361 431 137 105 141 132 51 41 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 47 4 

clinical_engagement 
diagnosis 
demography 
46 new agents 
19 
disease_progression 
H-positive risk:  882 905 102 960 422 138 871 358 131 42 141 48 
H-negative risk:  905 882 871 960 358 422 138 102 141 131 48 42 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 48 4 

clinical_engagement 
diagnosis 
demography 
77 new agents 
20 
disease_progression 
H-positive risk:  899 907 104 950 416 136 868 355 130 43 143 49 
H-negative risk:  907 899 868 950 355 416 136 104 143 130 49 43 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 50 4 

clinical_engagement 
diagnosis 
demography 
64 new agents 
21 
disease_progression 
H-positive risk:  905 913 105 948 410 136 867 350 130 45 141 50 
H-negative risk:  913 905 867 948 350 410 136 105 141 130 50 45 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 51 5 

clinical_engagement 
diagnosis 
demography 
58 new agents 
22 
disease_progression 
H-positive risk:  909 917 105 953 411 136 856 346 130 46 142 49 
H-negative risk:  917 909 856 953 346 411 136 105 142 130 49 46 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 51 7 

clinical_engagement 
diagnosis 
demography 
58 new agents 
23 
disease_progression 
H-positive risk:  908 928 105 952 409 134 854 341 132 48 140 49 
H-negative risk:  928 908 854 952 341 409 134 105 140 132 49 48 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 51 8 

clinical_engagement 
diagnosis 
demography 
57 new agents 
24 
disease_progression 
H-positive risk:  911 931 105 944 407 136 858 338 132 50 138 50 
H-negative risk:  931 911 858 944 338 407 136 105 138 132 50 50 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 51 9 

clinical_engagement 
diagnosis 
demography 
65 new agents 
25 
disease_progression 
H-positive risk:  839 858 101 1025 401 128 934 335 139 47 143 50 
H-negative risk:  858 839 934 1025 335 401 128 101 143 139 50 47 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 52 10 

clinical_engagement 
diagnosis 
demography 
201 new agents 
26 
disease_progression 
H-positive risk:  870 870 107 991 391 133 911 359 136 46 133 53 
H-negative risk:  870 870 911 991 359 391 133 107 133 136 53 46 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 55 11 

clinical_engagement 
diagnosis 
demography 
74 new agents 
27 
disease_progression 
H-positive risk:  871 873 109 986 384 136 913 363 134 49 130 52 
H-negative risk:  873 871 913 986 363 384 136 109 130 134 52 49 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 56 12 

clinical_engagement 
diagnosis 
demography 
53 new agents 
28 
disease_progression 
H-positive risk:  873 873 110 982 388 136 909 361 135 49 131 53 
H-negative risk:  873 873 909 982 361 388 136 110 131 135 53 49 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 58 12 

clinical_engagement 
diagnosis 
demography 
73 new agents 
29 
disease_progression 
H-positive risk:  873 874 110 982 394 137 910 357 133 48 130 52 
H-negative risk:  874 873 910 982 357 394 137 110 130 133 52 48 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 61 12 

clinical_engagement 
diagnosis 
demography 
69 new agents 
30 
disease_progression 
H-positive risk:  879 876 109 977 393 138 910 357 131 49 129 52 
H-negative risk:  876 879 910 977 357 393 138 109 129 131 52 49 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 62 12 

clinical_engagement 
diagnosis 
demography 
59 new agents 
31 
disease_progression 
H-positive risk:  882 876 111 974 385 137 918 357 130 48 130 52 
H-negative risk:  876 882 918 974 357 385 137 111 130 130 52 48 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 65 12 

clinical_engagement 
diagnosis 
demography 
54 new agents 
32 
disease_progression 
H-positive risk:  889 875 113 978 381 140 918 349 128 47 129 53 
H-negative risk:  875 889 918 978 349 381 140 113 129 128 53 47 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 64 12 

clinical_engagement 
diagnosis 
demography 
58 new agents 
33 
disease_progression 
H-positive risk:  889 888 113 972 374 140 917 351 129 46 128 53 
H-negative risk:  888 889 917 972 351 374 140 113 128 129 53 46 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 63 12 

clinical_engagement 
diagnosis 
demography 
49 new agents 
34 
disease_progression 
H-positive risk:  895 888 116 966 381 142 914 348 130 42 126 52 
H-negative risk:  888 895 914 966 348 381 142 116 126 130 52 42 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 62 12 

clinical_engagement 
diagnosis 
demography 
56 new agents 
35 
disease_progression 
H-positive risk:  899 888 117 966 384 141 915 344 129 42 124 51 
H-negative risk:  888 899 915 966 344 384 141 117 124 129 51 42 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 61 13 

clinical_engagement 
diagnosis 
demography 
72 new agents 
36 
disease_progression 
H-positive risk:  902 892 118 965 379 143 920 337 130 42 122 50 
H-negative risk:  892 902 920 965 337 379 143 118 122 130 50 42 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 59 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
37 
disease_progression 
H-positive risk:  846 832 108 1030 377 125 983 333 148 39 130 49 
H-negative risk:  832 846 983 1030 333 377 125 108 130 148 49 39 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 59 15 

clinical_engagement 
diagnosis 
demography 
148 new agents 
38 
disease_progression 
H-positive risk:  864 858 114 991 388 126 937 363 142 42 121 54 
H-negative risk:  858 864 937 991 363 388 126 114 121 142 54 42 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 55 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
39 
disease_progression 
H-positive risk:  870 859 113 989 388 128 938 359 138 45 120 53 
H-negative risk:  859 870 938 989 359 388 128 113 120 138 53 45 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 53 17 

clinical_engagement 
diagnosis 
demography 
63 new agents 
40 
disease_progression 
H-positive risk:  879 860 113 986 391 127 937 354 137 44 121 51 
H-negative risk:  860 879 937 986 354 391 127 113 121 137 51 44 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 54 17 

clinical_engagement 
diagnosis 
demography 
48 new agents 
41 
disease_progression 
H-positive risk:  868 858 114 983 396 127 947 352 136 46 120 53 
H-negative risk:  858 868 947 983 352 396 127 114 120 136 53 46 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 56 17 

clinical_engagement 
diagnosis 
demography 
61 new agents 
42 
disease_progression 
H-positive risk:  862 857 114 989 398 126 950 348 138 46 121 51 
H-negative risk:  857 862 950 989 348 398 126 114 121 138 51 46 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 55 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
43 
disease_progression 
H-positive risk:  860 860 114 986 398 124 952 345 133 51 124 53 
H-negative risk:  860 860 952 986 345 398 124 114 124 133 53 51 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 55 19 

clinical_engagement 
diagnosis 
demography 
59 new agents 
44 
disease_progression 
H-positive risk:  859 862 113 980 396 125 956 347 134 50 124 54 
H-negative risk:  862 859 956 980 347 396 125 113 124 134 54 50 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 56 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
45 
disease_progression 
H-positive risk:  859 871 111 983 394 125 959 341 132 52 120 53 
H-negative risk:  871 859 959 983 341 394 125 111 120 132 53 52 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 57 22 

clinical_engagement 
diagnosis 
demography 
55 new agents 
46 
disease_progression 
H-positive risk:  854 868 109 982 398 126 962 343 132 55 119 52 
H-negative risk:  868 854 962 982 343 398 126 109 119 132 52 55 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 58 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
47 
disease_progression 
H-positive risk:  860 860 108 975 400 127 968 343 135 55 117 52 
H-negative risk:  860 860 968 975 343 400 127 108 117 135 52 55 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 60 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
48 
disease_progression 
H-positive risk:  859 865 108 971 399 129 967 342 135 54 117 54 
H-negative risk:  865 859 967 971 342 399 129 108 117 135 54 54 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 57 20 

clinical_engagement 
diagnosis 
demography 
55 new agents 
49 
disease_progression 
H-positive risk:  813 814 104 1017 395 121 1018 347 143 54 118 56 
H-negative risk:  814 813 1018 1017 347 395 121 104 118 143 56 54 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 60 20 

clinical_engagement 
diagnosis 
demography 
143 new agents 
50 
disease_progression 
H-positive risk:  820 827 105 988 405 123 989 374 137 64 108 60 
H-negative risk:  827 820 989 988 374 405 123 105 108 137 60 64 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 58 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
51 
disease_progression 
H-positive risk:  822 828 107 978 414 124 991 370 136 60 110 60 
H-negative risk:  828 822 991 978 370 414 124 107 110 136 60 60 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 60 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
52 
disease_progression 
H-positive risk:  827 829 108 982 412 124 992 361 138 61 109 57 
H-negative risk:  829 827 992 982 361 412 124 108 109 138 57 61 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 60 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
53 
disease_progression 
H-positive risk:  834 831 110 978 408 127 986 363 138 59 110 56 
H-negative risk:  831 834 986 978 363 408 127 110 110 138 56 59 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 61 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
54 
disease_progression 
H-positive risk:  837 832 109 977 410 126 984 365 137 57 108 58 
H-negative risk:  832 837 984 977 365 410 126 109 108 137 58 57 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 62 21 

clinical_engagement 
diagnosis 
demography 
57 new agents 
55 
disease_progression 
H-positive risk:  836 826 110 976 406 126 987 373 139 58 106 57 
H-negative risk:  826 836 987 976 373 406 126 110 106 139 57 58 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 64 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
56 
disease_progression 
H-positive risk:  840 829 111 970 412 122 988 372 136 56 104 60 
H-negative risk:  829 840 988 970 372 412 122 111 104 136 60 56 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
57 
disease_progression 
H-positive risk:  841 834 110 969 409 126 979 374 137 59 103 59 
H-negative risk:  834 841 979 969 374 409 126 110 103 137 59 59 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
58 
disease_progression 
H-positive risk:  854 830 109 973 405 125 973 371 137 61 102 60 
H-negative risk:  830 854 973 973 371 405 125 109 102 137 60 61 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 68 23 

clinical_engagement 
diagnosis 
demography 
61 new agents 
59 
disease_progression 
H-positive risk:  854 840 108 977 408 125 970 362 134 61 100 61 
H-negative risk:  840 854 970 977 362 408 125 108 100 134 61 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
53 new agents 
60 
disease_progression 
H-positive risk:  853 846 109 967 413 126 969 360 131 62 103 61 
H-negative risk:  846 853 969 967 360 413 126 109 103 131 61 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
61 
disease_progression 
H-positive risk:  802 795 105 1011 411 118 1028 356 139 62 112 61 
H-negative risk:  795 802 1028 1011 356 411 118 105 112 139 61 62 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
121 new agents 
62 
disease_progression 
H-positive risk:  814 809 105 974 423 117 1003 381 141 62 113 58 
H-negative risk:  809 814 1003 974 381 423 117 105 113 141 58 62 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
63 
disease_progression 
H-positive risk:  812 814 107 966 420 115 1009 380 140 65 115 57 
H-negative risk:  814 812 1009 966 380 420 115 107 115 140 57 65 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 70 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
64 
disease_progression 
H-positive risk:  814 812 107 964 424 115 1016 373 140 65 114 56 
H-negative risk:  812 814 1016 964 373 424 115 107 114 140 56 65 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 68 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
65 
disease_progression 
H-positive risk:  818 814 107 957 424 115 1012 376 141 64 115 57 
H-negative risk:  814 818 1012 957 376 424 115 107 115 141 57 64 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
94 new agents 
66 
disease_progression 
H-positive risk:  826 815 109 966 403 117 1020 370 142 63 115 54 
H-negative risk:  815 826 1020 966 370 403 117 109 115 142 54 63 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
67 
disease_progression 
H-positive risk:  831 819 110 967 407 118 1005 370 141 64 117 51 
H-negative risk:  819 831 1005 967 370 407 118 110 117 141 51 64 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
68 
disease_progression 
H-positive risk:  827 815 112 974 403 119 1007 370 140 65 117 51 
H-negative risk:  815 827 1007 974 370 403 119 112 117 140 51 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
60 new agents 
69 
disease_progression 
H-positive risk:  829 813 114 972 399 122 1009 370 141 64 117 50 
H-negative risk:  813 829 1009 972 370 399 122 114 117 141 50 64 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
70 
disease_progression 
H-positive risk:  832 818 115 960 400 122 1011 368 143 62 117 52 
H-negative risk:  818 832 1011 960 368 400 122 115 117 143 52 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
71 
disease_progression 
H-positive risk:  830 824 116 962 399 120 1007 370 146 59 117 50 
H-negative risk:  824 830 1007 962 370 399 120 116 117 146 50 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
57 new agents 
72 
disease_progression 
H-positive risk:  835 822 114 966 400 119 1000 371 148 59 115 51 
H-negative risk:  822 835 1000 966 371 400 119 114 115 148 51 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
60 new agents 
73 
disease_progression 
H-positive risk:  792 758 110 1033 392 115 1045 373 152 59 121 50 
H-negative risk:  758 792 1045 1033 373 392 115 110 121 152 50 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
122 new agents 
74 
disease_progression 
H-positive risk:  794 770 111 1018 398 118 1028 383 148 58 121 53 
H-negative risk:  770 794 1028 1018 383 398 118 111 121 148 53 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
75 
disease_progression 
H-positive risk:  796 771 110 1010 399 119 1030 384 147 55 123 56 
H-negative risk:  771 796 1030 1010 384 399 119 110 123 147 56 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
76 
disease_progression 
H-positive risk:  807 771 110 1009 392 121 1026 385 143 58 120 58 
H-negative risk:  771 807 1026 1009 385 392 121 110 120 143 58 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
60 new agents 
77 
disease_progression 
H-positive risk:  807 774 110 1009 386 123 1035 378 144 57 121 56 
H-negative risk:  774 807 1035 1009 378 386 123 110 121 144 56 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
85 new agents 
78 
disease_progression 
H-positive risk:  810 769 111 1013 387 123 1038 378 144 56 117 54 
H-negative risk:  769 810 1038 1013 378 387 123 111 117 144 54 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
79 
disease_progression 
H-positive risk:  810 767 114 1011 397 124 1039 371 142 56 116 53 
H-negative risk:  767 810 1039 1011 371 397 124 114 116 142 53 56 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
80 
disease_progression 
H-positive risk:  810 765 113 1023 386 120 1038 375 143 55 117 55 
H-negative risk:  765 810 1038 1023 375 386 120 113 117 143 55 55 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
81 
disease_progression 
H-positive risk:  808 773 111 1022 385 124 1038 373 141 55 116 54 
H-negative risk:  773 808 1038 1022 373 385 124 111 116 141 54 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
82 
disease_progression 
H-positive risk:  805 779 109 1024 382 125 1032 377 140 56 117 54 
H-negative risk:  779 805 1032 1024 377 382 125 109 117 140 54 56 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
83 
disease_progression 
H-positive risk:  810 781 110 1028 380 123 1038 372 139 55 115 49 
H-negative risk:  781 810 1038 1028 372 380 123 110 115 139 49 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
84 
disease_progression 
H-positive risk:  811 784 112 1021 375 124 1044 370 137 57 115 50 
H-negative risk:  784 811 1044 1021 370 375 124 112 115 137 50 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
85 
disease_progression 
H-positive risk:  776 736 104 1065 380 118 1077 372 141 55 126 50 
H-negative risk:  736 776 1077 1065 372 380 118 104 126 141 50 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
95 new agents 
86 
disease_progression 
H-positive risk:  761 731 105 1074 381 120 1072 381 136 59 129 51 
H-negative risk:  731 761 1072 1074 381 381 120 105 129 136 51 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
98 new agents 
87 
disease_progression 
H-positive risk:  769 733 108 1058 375 122 1073 385 133 60 131 53 
H-negative risk:  733 769 1073 1058 385 375 122 108 131 133 53 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
88 
disease_progression 
H-positive risk:  763 730 110 1048 383 123 1074 395 131 62 126 55 
H-negative risk:  730 763 1074 1048 395 383 123 110 126 131 55 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
89 
disease_progression 
H-positive risk:  761 730 113 1051 380 120 1080 392 133 60 128 52 
H-negative risk:  730 761 1080 1051 392 380 120 113 128 133 52 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
90 
disease_progression 
H-positive risk:  763 733 115 1046 379 122 1077 390 132 64 127 52 
H-negative risk:  733 763 1077 1046 390 379 122 115 127 132 52 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
91 
disease_progression 
H-positive risk:  759 740 115 1045 374 121 1081 390 135 63 126 51 
H-negative risk:  740 759 1081 1045 390 374 121 115 126 135 51 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
59 new agents 
92 
disease_progression 
H-positive risk:  763 737 112 1052 373 123 1080 383 134 62 129 52 
H-negative risk:  737 763 1080 1052 383 373 123 112 129 134 52 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
93 
disease_progression 
H-positive risk:  768 733 112 1059 370 122 1083 383 131 59 128 52 
H-negative risk:  733 768 1083 1059 383 370 122 112 128 131 52 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
94 
disease_progression 
H-positive risk:  770 741 113 1053 362 121 1094 377 130 57 130 52 
H-negative risk:  741 770 1094 1053 377 362 121 113 130 130 52 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
62 new agents 
95 
disease_progression 
H-positive risk:  771 744 116 1053 361 121 1096 370 129 56 128 55 
H-negative risk:  744 771 1096 1053 370 361 121 116 128 129 55 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
96 
disease_progression 
H-positive risk:  775 748 119 1053 352 120 1094 369 126 56 132 56 
H-negative risk:  748 775 1094 1053 369 352 120 119 132 126 56 56 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 96 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
97 
disease_progression 
H-positive risk:  730 692 112 1106 352 104 1143 369 142 54 141 55 
H-negative risk:  692 730 1143 1106 369 352 104 112 141 142 55 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 96 19 

clinical_engagement 
diagnosis 
demography 
94 new agents 
98 
disease_progression 
H-positive risk:  736 685 113 1091 367 100 1127 385 146 54 136 60 
H-negative risk:  685 736 1127 1091 385 367 100 113 136 146 60 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 97 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
99 
disease_progression 
H-positive risk:  733 689 112 1096 368 102 1128 387 143 50 131 61 
H-negative risk:  689 733 1128 1096 387 368 102 112 131 143 61 50 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
100 
disease_progression 
H-positive risk:  736 695 114 1091 362 101 1118 392 146 47 137 61 
H-negative risk:  695 736 1118 1091 392 362 101 114 137 146 61 47 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 97 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
101 
disease_progression 
H-positive risk:  730 695 116 1090 368 102 1120 390 148 45 134 62 
H-negative risk:  695 730 1120 1090 390 368 102 116 134 148 62 45 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 95 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
102 
disease_progression 
H-positive risk:  732 687 117 1092 367 105 1127 386 149 44 134 60 
H-negative risk:  687 732 1127 1092 386 367 105 117 134 149 60 44 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 95 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
103 
disease_progression 
H-positive risk:  734 685 115 1095 360 105 1128 394 145 41 138 60 
H-negative risk:  685 734 1128 1095 394 360 105 115 138 145 60 41 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 95 17 

clinical_engagement 
diagnosis 
demography 
61 new agents 
104 
disease_progression 
H-positive risk:  737 692 113 1087 361 106 1129 391 145 42 138 59 
H-negative risk:  692 737 1129 1087 391 361 106 113 138 145 59 42 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 97 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
105 
disease_progression 
H-positive risk:  736 682 112 1088 364 109 1133 393 140 43 139 61 
H-negative risk:  682 736 1133 1088 393 364 109 112 139 140 61 43 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 95 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
106 
disease_progression 
H-positive risk:  736 682 113 1088 365 108 1128 399 140 42 139 60 
H-negative risk:  682 736 1128 1088 399 365 108 113 139 140 60 42 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 96 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
107 
disease_progression 
H-positive risk:  744 676 114 1088 369 110 1125 396 139 43 137 59 
H-negative risk:  676 744 1125 1088 396 369 110 114 137 139 59 43 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 97 17 

clinical_engagement 
diagnosis 
demography 
59 new agents 
108 
disease_progression 
H-positive risk:  750 673 113 1089 375 112 1121 396 137 41 137 56 
H-negative risk:  673 750 1121 1089 396 375 112 113 137 137 56 41 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 99 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
109 
disease_progression 
H-positive risk:  715 654 109 1114 375 101 1155 389 149 42 144 53 
H-negative risk:  654 715 1155 1114 389 375 101 109 144 149 53 42 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 98 17 

clinical_engagement 
diagnosis 
demography 
101 new agents 
110 
disease_progression 
H-positive risk:  707 643 106 1112 388 101 1150 402 147 44 144 56 
H-negative risk:  643 707 1150 1112 402 388 101 106 144 147 56 44 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 99 16 

clinical_engagement 
diagnosis 
demography 
85 new agents 
111 
disease_progression 
H-positive risk:  705 644 105 1096 393 104 1155 406 148 45 144 55 
H-negative risk:  644 705 1155 1096 406 393 104 105 144 148 55 45 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 98 15 

clinical_engagement 
diagnosis 
demography 
76 new agents 
112 
disease_progression 
H-positive risk:  699 647 105 1095 391 105 1164 403 147 44 147 53 
H-negative risk:  647 699 1164 1095 403 391 105 105 147 147 53 44 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 99 14 

clinical_engagement 
diagnosis 
demography 
72 new agents 
113 
disease_progression 
H-positive risk:  707 657 102 1089 385 103 1164 399 146 43 153 52 
H-negative risk:  657 707 1164 1089 399 385 103 102 153 146 52 43 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 99 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
114 
disease_progression 
H-positive risk:  705 661 102 1093 381 101 1170 390 145 44 154 54 
H-negative risk:  661 705 1170 1093 390 381 101 102 154 145 54 44 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 100 14 

clinical_engagement 
diagnosis 
demography 
69 new agents 
115 
disease_progression 
H-positive risk:  707 660 96 1084 382 102 1171 396 148 43 158 53 
H-negative risk:  660 707 1171 1084 396 382 102 96 158 148 53 43 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 97 14 

clinical_engagement 
diagnosis 
demography 
67 new agents 
116 
disease_progression 
H-positive risk:  708 664 95 1080 385 105 1165 395 147 44 158 54 
H-negative risk:  664 708 1165 1080 395 385 105 95 158 147 54 44 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 97 14 

clinical_engagement 
diagnosis 
demography 
59 new agents 
117 
disease_progression 
H-positive risk:  706 673 95 1082 379 103 1170 389 143 47 157 56 
H-negative risk:  673 706 1170 1082 389 379 103 95 157 143 56 47 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 98 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
118 
disease_progression 
H-positive risk:  707 676 93 1077 378 106 1164 396 143 45 157 58 
H-negative risk:  676 707 1164 1077 396 378 106 93 157 143 58 45 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 99 14 

clinical_engagement 
diagnosis 
demography 
81 new agents 
119 
disease_progression 
H-positive risk:  697 678 91 1087 369 108 1166 400 140 47 160 57 
H-negative risk:  678 697 1166 1087 400 369 108 91 160 140 57 47 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 102 14 

clinical_engagement 
diagnosis 
demography 
64 new agents 
120 
disease_progression 
H-positive risk:  703 685 91 1085 363 107 1174 387 144 48 155 58 
H-negative risk:  685 703 1174 1085 387 363 107 91 155 144 58 48 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 103 14 

clinical_engagement 
diagnosis 
demography 
54 new agents 
121 
disease_progression 
H-positive risk:  654 631 86 1141 370 100 1222 377 152 48 158 61 
H-negative risk:  631 654 1222 1141 377 370 100 86 158 152 61 48 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 106 15 

clinical_engagement 
diagnosis 
demography 
81 new agents 
122 
disease_progression 
H-positive risk:  650 631 85 1124 381 103 1200 400 152 53 157 64 
H-negative risk:  631 650 1200 1124 400 381 103 85 157 152 64 53 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 108 15 

clinical_engagement 
diagnosis 
demography 
82 new agents 
123 
disease_progression 
H-positive risk:  648 632 88 1126 382 102 1201 403 150 53 154 61 
H-negative risk:  632 648 1201 1126 403 382 102 88 154 150 61 53 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 109 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
124 
disease_progression 
H-positive risk:  657 629 91 1132 374 102 1194 406 149 54 152 60 
H-negative risk:  629 657 1194 1132 406 374 102 91 152 149 60 54 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 106 15 

clinical_engagement 
diagnosis 
demography 
76 new agents 
125 
disease_progression 
H-positive risk:  659 622 92 1127 379 102 1195 409 154 54 149 58 
H-negative risk:  622 659 1195 1127 409 379 102 92 149 154 58 54 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 105 15 

clinical_engagement 
diagnosis 
demography 
93 new agents 
126 
disease_progression 
H-positive risk:  659 622 95 1122 376 104 1195 417 153 55 145 57 
H-negative risk:  622 659 1195 1122 417 376 104 95 145 153 57 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 101 16 

clinical_engagement 
diagnosis 
demography 
83 new agents 
127 
disease_progression 
H-positive risk:  666 635 95 1112 373 103 1202 410 154 53 142 55 
H-negative risk:  635 666 1202 1112 410 373 103 95 142 154 55 53 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 104 16 

clinical_engagement 
diagnosis 
demography 
53 new agents 
128 
disease_progression 
H-positive risk:  665 631 93 1112 373 107 1203 412 151 54 143 56 
H-negative risk:  631 665 1203 1112 412 373 107 93 143 151 56 54 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 104 16 

clinical_engagement 
diagnosis 
demography 
89 new agents 
129 
disease_progression 
H-positive risk:  668 630 93 1123 366 108 1205 407 152 52 142 54 
H-negative risk:  630 668 1205 1123 407 366 108 93 142 152 54 52 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 105 16 

clinical_engagement 
diagnosis 
demography 
87 new agents 
130 
disease_progression 
H-positive risk:  674 628 96 1119 370 112 1201 402 154 52 141 51 
H-negative risk:  628 674 1201 1119 402 370 112 96 141 154 51 52 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 104 16 

clinical_engagement 
diagnosis 
demography 
77 new agents 
131 
disease_progression 
H-positive risk:  669 635 96 1124 370 110 1197 400 154 53 143 49 
H-negative risk:  635 669 1197 1124 400 370 110 96 143 154 49 53 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 103 16 

clinical_engagement 
diagnosis 
demography 
64 new agents 
132 
disease_progression 
H-positive risk:  672 641 95 1124 370 109 1191 398 155 53 143 49 
H-negative risk:  641 672 1191 1124 398 370 109 95 143 155 49 53 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 104 15 

clinical_engagement 
diagnosis 
demography 
69 new agents 
133 
disease_progression 
H-positive risk:  674 642 95 1122 368 110 1179 411 155 54 142 48 
H-negative risk:  642 674 1179 1122 411 368 110 95 142 155 48 54 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 104 15 

clinical_engagement 
diagnosis 
demography 
74 new agents 
134 
disease_progression 
H-positive risk:  675 639 94 1120 369 109 1176 420 152 57 140 49 
H-negative risk:  639 675 1176 1120 420 369 109 94 140 152 49 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 99 17 

clinical_engagement 
diagnosis 
demography 
105 new agents 
135 
disease_progression 
H-positive risk:  684 641 97 1132 362 110 1162 425 146 55 140 46 
H-negative risk:  641 684 1162 1132 425 362 110 97 140 146 46 55 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 98 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
136 
disease_progression 
H-positive risk:  677 636 99 1126 362 114 1162 430 146 58 144 46 
H-negative risk:  636 677 1162 1126 430 362 114 99 144 146 46 58 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 96 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
137 
disease_progression 
H-positive risk:  680 646 102 1119 367 112 1159 423 146 59 142 45 
H-negative risk:  646 680 1159 1119 423 367 112 102 142 146 45 59 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 98 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
138 
disease_progression 
H-positive risk:  683 647 102 1116 368 111 1161 420 142 62 141 47 
H-negative risk:  647 683 1161 1116 420 368 111 102 141 142 47 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 96 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
139 
disease_progression 
H-positive risk:  675 649 103 1122 361 108 1172 414 142 63 144 47 
H-negative risk:  649 675 1172 1122 414 361 108 103 144 142 47 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 96 17 

clinical_engagement 
diagnosis 
demography 
60 new agents 
140 
disease_progression 
H-positive risk:  681 647 105 1123 355 108 1168 415 143 63 144 48 
H-negative risk:  647 681 1168 1123 415 355 108 105 144 143 48 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 94 15 

clinical_engagement 
diagnosis 
demography 
64 new agents 
141 
disease_progression 
H-positive risk:  678 649 106 1132 350 109 1169 410 142 60 145 50 
H-negative risk:  649 678 1169 1132 410 350 109 106 145 142 50 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 97 14 

clinical_engagement 
diagnosis 
demography 
84 new agents 
142 
disease_progression 
H-positive risk:  672 645 104 1142 347 107 1174 405 145 59 152 48 
H-negative risk:  645 672 1174 1142 405 347 107 104 152 145 48 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 95 14 

clinical_engagement 
diagnosis 
demography 
102 new agents 
143 
disease_progression 
H-positive risk:  668 647 103 1142 342 108 1185 404 148 56 151 46 
H-negative risk:  647 668 1185 1142 404 342 108 103 151 148 46 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 90 16 

clinical_engagement 
diagnosis 
demography 
94 new agents 
144 
disease_progression 
H-positive risk:  668 651 102 1148 341 109 1184 400 148 53 152 44 
H-negative risk:  651 668 1184 1148 400 341 109 102 152 148 44 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
145 
disease_progression 
H-positive risk:  673 647 102 1154 347 107 1183 397 148 50 151 41 
H-negative risk:  647 673 1183 1154 397 347 107 102 151 148 41 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
146 
disease_progression 
H-positive risk:  657 654 100 1140 368 108 1183 398 147 49 154 42 
H-negative risk:  654 657 1183 1140 398 368 108 100 154 147 42 49 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
92 new agents 
147 
disease_progression 
H-positive risk:  666 651 99 1139 367 107 1182 392 149 51 154 43 
H-negative risk:  651 666 1182 1139 392 367 107 99 154 149 43 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
80 new agents 
148 
disease_progression 
H-positive risk:  675 657 97 1133 361 104 1181 389 153 51 158 41 
H-negative risk:  657 675 1181 1133 389 361 104 97 158 153 41 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 88 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
149 
disease_progression 
H-positive risk:  677 654 96 1147 357 103 1169 389 153 52 159 44 
H-negative risk:  654 677 1169 1147 389 357 103 96 159 153 44 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
150 
disease_progression 
H-positive risk:  687 654 91 1144 353 103 1167 387 153 53 164 44 
H-negative risk:  654 687 1167 1144 387 353 103 91 164 153 44 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
56 new agents 
151 
disease_progression 
H-positive risk:  684 654 86 1147 358 103 1165 385 152 52 168 46 
H-negative risk:  654 684 1165 1147 385 358 103 86 168 152 46 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 85 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
152 
disease_progression 
H-positive risk:  685 653 87 1151 360 103 1164 376 155 53 165 48 
H-negative risk:  653 685 1164 1151 376 360 103 87 165 155 48 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 85 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
153 
disease_progression 
H-positive risk:  678 648 82 1160 357 104 1172 382 153 54 162 48 
H-negative risk:  648 678 1172 1160 382 357 104 82 162 153 48 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 83 17 

clinical_engagement 
diagnosis 
demography 
81 new agents 
154 
disease_progression 
H-positive risk:  674 655 81 1155 357 105 1171 379 154 54 170 45 
H-negative risk:  655 674 1171 1155 379 357 105 81 170 154 45 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
155 
disease_progression 
H-positive risk:  681 651 81 1153 367 108 1168 375 150 53 169 44 
H-negative risk:  651 681 1168 1153 375 367 108 81 169 150 44 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
91 new agents 
156 
disease_progression 
H-positive risk:  680 651 84 1147 361 111 1166 385 152 51 168 44 
H-negative risk:  651 680 1166 1147 385 361 111 84 168 152 44 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
63 new agents 
157 
disease_progression 
H-positive risk:  677 656 83 1147 360 115 1166 386 150 51 166 43 
H-negative risk:  656 677 1166 1147 386 360 115 83 166 150 43 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
94 new agents 
158 
disease_progression 
H-positive risk:  676 653 81 1151 367 115 1163 389 146 53 162 44 
H-negative risk:  653 676 1163 1151 389 367 115 81 162 146 44 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 86 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
159 
disease_progression 
H-positive risk:  677 655 77 1143 360 116 1168 392 148 53 166 45 
H-negative risk:  655 677 1168 1143 392 360 116 77 166 148 45 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
74 new agents 
160 
disease_progression 
H-positive risk:  680 657 77 1152 353 117 1160 389 146 55 167 47 
H-negative risk:  657 680 1160 1152 389 353 117 77 167 146 47 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
161 
disease_progression 
H-positive risk:  685 659 78 1154 353 120 1149 391 143 56 161 51 
H-negative risk:  659 685 1149 1154 391 353 120 78 161 143 51 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 88 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
162 
disease_progression 
H-positive risk:  684 654 78 1156 353 117 1151 392 148 55 162 50 
H-negative risk:  654 684 1151 1156 392 353 117 78 162 148 50 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 90 15 

clinical_engagement 
diagnosis 
demography 
84 new agents 
163 
disease_progression 
H-positive risk:  685 662 78 1160 354 113 1143 389 153 54 159 50 
H-negative risk:  662 685 1143 1160 389 354 113 78 159 153 50 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 92 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
164 
disease_progression 
H-positive risk:  689 657 80 1152 354 113 1142 393 154 54 161 51 
H-negative risk:  657 689 1142 1152 393 354 113 80 161 154 51 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 93 14 

clinical_engagement 
diagnosis 
demography 
67 new agents 
165 
disease_progression 
H-positive risk:  679 654 79 1165 355 111 1143 397 152 56 159 50 
H-negative risk:  654 679 1143 1165 397 355 111 79 159 152 50 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
166 
disease_progression 
H-positive risk:  689 650 82 1161 361 111 1129 406 152 56 155 48 
H-negative risk:  650 689 1129 1161 406 361 111 82 155 152 48 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 90 15 

clinical_engagement 
diagnosis 
demography 
88 new agents 
167 
disease_progression 
H-positive risk:  690 652 84 1155 359 112 1133 404 149 59 150 53 
H-negative risk:  652 690 1133 1155 404 359 112 84 150 149 53 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
69 new agents 
168 
disease_progression 
H-positive risk:  700 648 82 1147 361 111 1131 408 152 56 151 53 
H-negative risk:  648 700 1131 1147 408 361 111 82 151 152 53 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
169 
disease_progression 
H-positive risk:  702 647 86 1146 360 111 1119 415 153 56 153 52 
H-negative risk:  647 702 1119 1146 415 360 111 86 153 153 52 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 91 15 

clinical_engagement 
diagnosis 
demography 
72 new agents 
170 
disease_progression 
H-positive risk:  697 647 81 1137 373 111 1122 419 151 55 155 52 
H-negative risk:  647 697 1122 1137 419 373 111 81 155 151 52 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 93 16 

clinical_engagement 
diagnosis 
demography 
97 new agents 
171 
disease_progression 
H-positive risk:  701 657 84 1134 367 112 1122 411 149 57 152 54 
H-negative risk:  657 701 1122 1134 411 367 112 84 152 149 54 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 92 15 

clinical_engagement 
diagnosis 
demography 
74 new agents 
172 
disease_progression 
H-positive risk:  685 663 85 1129 369 112 1131 410 148 60 155 53 
H-negative risk:  663 685 1131 1129 410 369 112 85 155 148 53 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 91 15 

clinical_engagement 
diagnosis 
demography 
79 new agents 
173 
disease_progression 
H-positive risk:  684 664 87 1125 364 112 1138 409 153 58 152 54 
H-negative risk:  664 684 1138 1125 409 364 112 87 152 153 54 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 92 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
174 
disease_progression 
H-positive risk:  677 666 84 1130 365 115 1136 409 153 57 152 56 
H-negative risk:  666 677 1136 1130 409 365 115 84 152 153 56 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 91 15 

clinical_engagement 
diagnosis 
demography 
80 new agents 
175 
disease_progression 
H-positive risk:  675 667 86 1130 368 117 1133 404 153 55 156 56 
H-negative risk:  667 675 1133 1130 404 368 117 86 156 153 56 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 90 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
176 
disease_progression 
H-positive risk:  671 671 83 1132 368 117 1129 405 153 54 158 59 
H-negative risk:  671 671 1129 1132 405 368 117 83 158 153 59 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 89 17 

clinical_engagement 
diagnosis 
demography 
79 new agents 
177 
disease_progression 
H-positive risk:  671 676 86 1132 367 114 1124 404 153 53 159 61 
H-negative risk:  676 671 1124 1132 404 367 114 86 159 153 61 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 83 17 

clinical_engagement 
diagnosis 
demography 
90 new agents 
178 
disease_progression 
H-positive risk:  667 684 89 1123 362 114 1135 405 152 53 155 61 
H-negative risk:  684 667 1135 1123 405 362 114 89 155 152 61 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
179 
disease_progression 
H-positive risk:  665 682 89 1127 368 115 1132 404 152 51 153 62 
H-negative risk:  682 665 1132 1127 404 368 115 89 153 152 62 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
180 
disease_progression 
H-positive risk:  660 691 90 1124 373 117 1126 407 153 50 150 59 
H-negative risk:  691 660 1126 1124 407 373 117 90 150 153 59 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 82 17 

clinical_engagement 
diagnosis 
demography 
91 new agents 
181 
disease_progression 
H-positive risk:  665 692 90 1124 372 116 1122 406 153 49 153 58 
H-negative risk:  692 665 1122 1124 406 372 116 90 153 153 58 49 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
182 
disease_progression 
H-positive risk:  666 696 91 1122 369 115 1120 406 150 51 152 62 
H-negative risk:  696 666 1120 1122 406 369 115 91 152 150 62 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
183 
disease_progression 
H-positive risk:  661 696 90 1117 368 113 1130 409 155 48 154 59 
H-negative risk:  696 661 1130 1117 409 368 113 90 154 155 59 48 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
55 new agents 
184 
disease_progression 
H-positive risk:  665 692 90 1124 365 113 1129 410 156 46 151 59 
H-negative risk:  692 665 1129 1124 410 365 113 90 151 156 59 46 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
93 new agents 
185 
disease_progression 
H-positive risk:  674 700 89 1118 361 111 1120 413 155 49 148 62 
H-negative risk:  700 674 1120 1118 413 361 111 89 148 155 62 49 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
186 
disease_progression 
H-positive risk:  669 701 89 1118 367 109 1119 415 155 52 146 60 
H-negative risk:  701 669 1119 1118 415 367 109 89 146 155 60 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
187 
disease_progression 
H-positive risk:  679 697 86 1130 362 107 1111 417 155 50 148 58 
H-negative risk:  697 679 1111 1130 417 362 107 86 148 155 58 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
188 
disease_progression 
H-positive risk:  682 696 87 1126 362 104 1117 410 158 48 150 60 
H-negative risk:  696 682 1117 1126 410 362 104 87 150 158 60 48 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
65 new agents 
189 
disease_progression 
H-positive risk:  683 697 87 1127 360 100 1120 410 162 46 149 59 
H-negative risk:  697 683 1120 1127 410 360 100 87 149 162 59 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 68 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
190 
disease_progression 
H-positive risk:  680 692 84 1136 359 96 1122 405 167 49 152 58 
H-negative risk:  692 680 1122 1136 405 359 96 84 152 167 58 49 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 68 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
191 
disease_progression 
H-positive risk:  676 686 82 1138 362 95 1125 409 168 50 151 58 
H-negative risk:  686 676 1125 1138 409 362 95 82 151 168 58 50 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 67 29 

clinical_engagement 
diagnosis 
demography 
86 new agents 
192 
disease_progression 
H-positive risk:  681 692 83 1139 361 93 1119 407 167 51 148 59 
H-negative risk:  692 681 1119 1139 407 361 93 83 148 167 59 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
193 
disease_progression 
H-positive risk:  683 696 83 1136 365 95 1113 408 162 51 148 60 
H-negative risk:  696 683 1113 1136 408 365 95 83 148 162 60 51 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 66 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
194 
disease_progression 
H-positive risk:  690 695 80 1130 379 96 1108 404 161 51 148 58 
H-negative risk:  695 690 1108 1130 404 379 96 80 148 161 58 51 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 66 29 

clinical_engagement 
diagnosis 
demography 
60 new agents 
195 
disease_progression 
H-positive risk:  682 693 78 1135 382 93 1101 413 164 52 149 58 
H-negative risk:  693 682 1101 1135 413 382 93 78 149 164 58 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 66 31 

clinical_engagement 
diagnosis 
demography 
70 new agents 
196 
disease_progression 
H-positive risk:  683 697 79 1129 383 92 1101 412 169 51 146 58 
H-negative risk:  697 683 1101 1129 412 383 92 79 146 169 58 51 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 66 30 

clinical_engagement 
diagnosis 
demography 
86 new agents 
197 
disease_progression 
H-positive risk:  683 693 81 1138 371 94 1100 420 170 50 145 55 
H-negative risk:  693 683 1100 1138 420 371 94 81 145 170 55 50 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 64 32 

clinical_engagement 
diagnosis 
demography 
67 new agents 
198 
disease_progression 
H-positive risk:  688 687 81 1136 376 93 1092 426 174 52 144 51 
H-negative risk:  687 688 1092 1136 426 376 93 81 144 174 51 52 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 62 32 

clinical_engagement 
diagnosis 
demography 
63 new agents 
199 
disease_progression 
H-positive risk:  691 688 81 1135 380 94 1087 427 172 52 142 51 
H-negative risk:  688 691 1087 1135 427 380 94 81 142 172 51 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 62 33 

clinical_engagement 
diagnosis 
demography 
88 new agents 
200 
disease_progression 
H-positive risk:  697 697 82 1136 370 95 1081 427 172 52 141 50 
H-negative risk:  697 697 1081 1136 427 370 95 82 141 172 50 52 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 61 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
201 
disease_progression 
H-positive risk:  700 690 85 1127 373 96 1081 430 173 54 142 49 
H-negative risk:  690 700 1081 1127 430 373 96 85 142 173 49 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 63 34 

clinical_engagement 
diagnosis 
demography 
90 new agents 
202 
disease_progression 
H-positive risk:  699 688 85 1117 374 94 1084 435 175 54 145 50 
H-negative risk:  688 699 1084 1117 435 374 94 85 145 175 50 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 62 35 

clinical_engagement 
diagnosis 
demography 
76 new agents 
203 
disease_progression 
H-positive risk:  702 692 82 1099 386 94 1087 434 172 55 145 52 
H-negative risk:  692 702 1087 1099 434 386 94 82 145 172 52 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 61 34 

clinical_engagement 
diagnosis 
demography 
64 new agents 
204 
disease_progression 
H-positive risk:  701 696 82 1096 386 94 1087 431 174 56 143 54 
H-negative risk:  696 701 1087 1096 431 386 94 82 143 174 54 56 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 63 32 

clinical_engagement 
diagnosis 
demography 
84 new agents 
205 
disease_progression 
H-positive risk:  698 691 88 1090 381 95 1091 432 175 56 148 55 
H-negative risk:  691 698 1091 1090 432 381 95 88 148 175 55 56 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 61 32 

clinical_engagement 
diagnosis 
demography 
85 new agents 
206 
disease_progression 
H-positive risk:  698 699 90 1088 383 91 1090 427 171 57 151 55 
H-negative risk:  699 698 1090 1088 427 383 91 90 151 171 55 57 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 60 31 

clinical_engagement 
diagnosis 
demography 
56 new agents 
207 
disease_progression 
H-positive risk:  701 693 89 1084 394 90 1078 434 173 56 151 57 
H-negative risk:  693 701 1078 1084 434 394 90 89 151 173 57 56 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 59 31 

clinical_engagement 
diagnosis 
demography 
87 new agents 
208 
disease_progression 
H-positive risk:  702 694 90 1082 401 90 1081 430 171 52 150 57 
H-negative risk:  694 702 1081 1082 430 401 90 90 150 171 57 52 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 61 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
209 
disease_progression 
H-positive risk:  700 693 89 1078 401 93 1087 430 166 56 151 56 
H-negative risk:  693 700 1087 1078 430 401 93 89 151 166 56 56 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 61 32 

clinical_engagement 
diagnosis 
demography 
77 new agents 
210 
disease_progression 
H-positive risk:  701 687 90 1088 399 94 1088 423 163 57 153 57 
H-negative risk:  687 701 1088 1088 423 399 94 90 153 163 57 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 61 31 

clinical_engagement 
diagnosis 
demography 
78 new agents 
211 
disease_progression 
H-positive risk:  706 691 87 1086 397 94 1090 421 162 55 155 56 
H-negative risk:  691 706 1090 1086 421 397 94 87 155 162 56 55 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 61 30 

clinical_engagement 
diagnosis 
demography 
84 new agents 
212 
disease_progression 
H-positive risk:  704 694 89 1087 395 90 1084 429 165 54 154 55 
H-negative risk:  694 704 1084 1087 429 395 90 89 154 165 55 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 59 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
213 
disease_progression 
H-positive risk:  704 695 91 1086 399 90 1080 428 164 55 151 57 
H-negative risk:  695 704 1080 1086 428 399 90 91 151 164 57 55 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 60 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
214 
disease_progression 
H-positive risk:  704 696 91 1086 398 89 1085 427 165 52 149 58 
H-negative risk:  696 704 1085 1086 427 398 89 91 149 165 58 52 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 57 29 

clinical_engagement 
diagnosis 
demography 
93 new agents 
215 
disease_progression 
H-positive risk:  707 701 91 1076 397 89 1089 424 165 52 147 62 
H-negative risk:  701 707 1089 1076 424 397 89 91 147 165 62 52 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 58 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
216 
disease_progression 
H-positive risk:  703 706 91 1081 398 89 1093 418 162 54 147 58 
H-negative risk:  706 703 1093 1081 418 398 89 91 147 162 58 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 59 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
217 
disease_progression 
H-positive risk:  707 716 88 1069 400 92 1092 416 158 57 146 59 
H-negative risk:  716 707 1092 1069 416 400 92 88 146 158 59 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 62 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
218 
disease_progression 
H-positive risk:  715 712 86 1077 399 92 1092 406 160 57 145 59 
H-negative risk:  712 715 1092 1077 406 399 92 86 145 160 59 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 63 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
219 
disease_progression 
H-positive risk:  715 717 83 1074 401 89 1088 408 161 57 149 58 
H-negative risk:  717 715 1088 1074 408 401 89 83 149 161 58 57 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 60 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
220 
disease_progression 
H-positive risk:  715 715 81 1087 401 91 1077 414 160 57 147 55 
H-negative risk:  715 715 1077 1087 414 401 91 81 147 160 55 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 59 31 

clinical_engagement 
diagnosis 
demography 
83 new agents 
221 
disease_progression 
H-positive risk:  715 708 81 1092 409 91 1077 408 162 57 147 53 
H-negative risk:  708 715 1077 1092 408 409 91 81 147 162 53 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 61 31 

clinical_engagement 
diagnosis 
demography 
70 new agents 
222 
disease_progression 
H-positive risk:  724 710 84 1087 411 90 1073 405 162 54 145 55 
H-negative risk:  710 724 1073 1087 405 411 90 84 145 162 55 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 62 32 

clinical_engagement 
diagnosis 
demography 
69 new agents 
223 
disease_progression 
H-positive risk:  723 706 82 1087 409 87 1079 411 162 52 146 56 
H-negative risk:  706 723 1079 1087 411 409 87 82 146 162 56 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 67 31 

clinical_engagement 
diagnosis 
demography 
70 new agents 
224 
disease_progression 
H-positive risk:  722 713 82 1084 405 88 1080 412 158 53 144 59 
H-negative risk:  713 722 1080 1084 412 405 88 82 144 158 59 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 70 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
225 
disease_progression 
H-positive risk:  720 714 81 1072 409 91 1083 414 159 54 143 60 
H-negative risk:  714 720 1083 1072 414 409 91 81 143 159 60 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 68 33 

clinical_engagement 
diagnosis 
demography 
80 new agents 
226 
disease_progression 
H-positive risk:  715 717 78 1064 415 89 1095 410 159 55 144 59 
H-negative risk:  717 715 1095 1064 410 415 89 78 144 159 59 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 66 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
227 
disease_progression 
H-positive risk:  717 723 78 1065 409 93 1095 410 158 51 144 57 
H-negative risk:  723 717 1095 1065 410 409 93 78 144 158 57 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 66 32 

clinical_engagement 
diagnosis 
demography 
65 new agents 
228 
disease_progression 
H-positive risk:  719 718 76 1069 410 91 1092 409 158 52 144 62 
H-negative risk:  718 719 1092 1069 409 410 91 76 144 158 62 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 66 31 

clinical_engagement 
diagnosis 
demography 
82 new agents 
229 
disease_progression 
H-positive risk:  719 715 73 1075 408 89 1081 419 155 56 146 64 
H-negative risk:  715 719 1081 1075 419 408 89 73 146 155 64 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 68 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
230 
disease_progression 
H-positive risk:  729 711 75 1085 399 90 1070 419 153 57 148 64 
H-negative risk:  711 729 1070 1085 419 399 90 75 148 153 64 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
231 
disease_progression 
H-positive risk:  728 719 78 1082 390 92 1064 426 151 55 146 69 
H-negative risk:  719 728 1064 1082 426 390 92 78 146 151 69 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
232 
disease_progression 
H-positive risk:  729 723 75 1075 392 93 1061 430 146 56 151 69 
H-negative risk:  723 729 1061 1075 430 392 93 75 151 146 69 56 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 66 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
233 
disease_progression 
H-positive risk:  728 727 74 1072 390 91 1061 427 152 58 149 71 
H-negative risk:  727 728 1061 1072 427 390 91 74 149 152 71 58 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 67 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
234 
disease_progression 
H-positive risk:  726 720 75 1082 384 92 1071 427 152 54 149 68 
H-negative risk:  720 726 1071 1082 427 384 92 75 149 152 68 54 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
235 
disease_progression 
H-positive risk:  730 714 76 1080 389 89 1072 427 152 53 149 69 
H-negative risk:  714 730 1072 1080 427 389 89 76 149 152 69 53 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 68 24 

clinical_engagement 
diagnosis 
demography 
55 new agents 
236 
disease_progression 
H-positive risk:  725 712 76 1080 392 90 1067 427 156 54 151 70 
H-negative risk:  712 725 1067 1080 427 392 90 76 151 156 70 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
237 
disease_progression 
H-positive risk:  724 708 75 1085 388 92 1074 429 154 53 149 69 
H-negative risk:  708 724 1074 1085 429 388 92 75 149 154 69 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
238 
disease_progression 
H-positive risk:  715 705 75 1083 397 91 1083 428 155 54 144 70 
H-negative risk:  705 715 1083 1083 428 397 91 75 144 155 70 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
239 
disease_progression 
H-positive risk:  715 697 74 1101 396 88 1081 422 158 53 143 72 
H-negative risk:  697 715 1081 1101 422 396 88 74 143 158 72 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
240 
disease_progression 
H-positive risk:  718 695 76 1103 394 92 1080 423 155 53 142 69 
H-negative risk:  695 718 1080 1103 423 394 92 76 142 155 69 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
241 
disease_progression 
H-positive risk:  719 687 79 1091 412 93 1067 433 155 54 142 68 
H-negative risk:  687 719 1067 1091 433 412 93 79 142 155 68 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
242 
disease_progression 
H-positive risk:  711 695 78 1096 401 92 1074 436 156 52 142 67 
H-negative risk:  695 711 1074 1096 436 401 92 78 142 156 67 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
243 
disease_progression 
H-positive risk:  709 685 81 1094 400 94 1086 431 155 57 143 65 
H-negative risk:  685 709 1086 1094 431 400 94 81 143 155 65 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
244 
disease_progression 
H-positive risk:  705 685 81 1098 410 95 1085 422 156 54 143 66 
H-negative risk:  685 705 1085 1098 422 410 95 81 143 156 66 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
245 
disease_progression 
H-positive risk:  697 692 83 1094 417 94 1093 412 157 52 145 64 
H-negative risk:  692 697 1093 1094 412 417 94 83 145 157 64 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
246 
disease_progression 
H-positive risk:  695 691 86 1095 419 97 1091 413 154 51 146 62 
H-negative risk:  691 695 1091 1095 413 419 97 86 146 154 62 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
247 
disease_progression 
H-positive risk:  686 696 87 1083 423 96 1096 421 152 51 147 62 
H-negative risk:  696 686 1096 1083 421 423 96 87 147 152 62 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
248 
disease_progression 
H-positive risk:  685 694 87 1094 420 98 1104 408 154 51 145 60 
H-negative risk:  694 685 1104 1094 408 420 98 87 145 154 60 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
249 
disease_progression 
H-positive risk:  689 697 87 1088 425 98 1090 413 153 53 147 60 
H-negative risk:  697 689 1090 1088 413 425 98 87 147 153 60 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
250 
disease_progression 
H-positive risk:  683 695 89 1094 428 98 1085 417 153 53 146 59 
H-negative risk:  695 683 1085 1094 417 428 98 89 146 153 59 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
251 
disease_progression 
H-positive risk:  683 696 89 1102 422 99 1088 413 150 52 144 62 
H-negative risk:  696 683 1088 1102 413 422 99 89 144 150 62 52 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
252 
disease_progression 
H-positive risk:  686 691 85 1104 423 101 1089 407 152 55 142 65 
H-negative risk:  691 686 1089 1104 407 423 101 85 142 152 65 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
253 
disease_progression 
H-positive risk:  690 689 85 1101 428 100 1090 405 153 54 141 64 
H-negative risk:  689 690 1090 1101 405 428 100 85 141 153 64 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
254 
disease_progression 
H-positive risk:  679 688 84 1105 429 97 1096 406 154 55 141 66 
H-negative risk:  688 679 1096 1105 406 429 97 84 141 154 66 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
255 
disease_progression 
H-positive risk:  672 689 83 1113 424 96 1100 405 154 55 144 65 
H-negative risk:  689 672 1100 1113 405 424 96 83 144 154 65 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
58 new agents 
256 
disease_progression 
H-positive risk:  674 688 86 1110 432 90 1095 404 154 57 145 65 
H-negative risk:  688 674 1095 1110 404 432 90 86 145 154 65 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
257 
disease_progression 
H-positive risk:  676 675 88 1115 431 91 1104 400 155 57 146 62 
H-negative risk:  675 676 1104 1115 400 431 91 88 146 155 62 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
258 
disease_progression 
H-positive risk:  674 676 85 1105 431 91 1110 409 156 56 146 61 
H-negative risk:  676 674 1110 1105 409 431 91 85 146 156 61 56 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
259 
disease_progression 
H-positive risk:  680 682 86 1099 424 91 1108 412 160 54 143 61 
H-negative risk:  682 680 1108 1099 412 424 91 86 143 160 61 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
58 new agents 
260 
disease_progression 
H-positive risk:  684 687 84 1096 422 90 1106 411 159 53 147 61 
H-negative risk:  687 684 1106 1096 411 422 90 84 147 159 61 53 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
261 
disease_progression 
H-positive risk:  688 688 84 1098 413 89 1105 415 156 54 150 60 
H-negative risk:  688 688 1105 1098 415 413 89 84 150 156 60 54 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 65 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
262 
disease_progression 
H-positive risk:  696 699 85 1084 417 91 1095 414 157 54 151 57 
H-negative risk:  699 696 1095 1084 414 417 91 85 151 157 57 54 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 64 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
263 
disease_progression 
H-positive risk:  692 694 84 1099 414 89 1094 412 160 54 149 59 
H-negative risk:  694 692 1094 1099 412 414 89 84 149 160 59 54 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 63 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
264 
disease_progression 
H-positive risk:  690 696 85 1106 418 87 1087 409 160 54 152 56 
H-negative risk:  696 690 1087 1106 409 418 87 85 152 160 56 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 64 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
265 
disease_progression 
H-positive risk:  685 705 89 1100 412 85 1087 408 166 53 154 56 
H-negative risk:  705 685 1087 1100 408 412 85 89 154 166 56 53 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 65 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
266 
disease_progression 
H-positive risk:  684 706 91 1106 414 87 1084 404 165 53 153 53 
H-negative risk:  706 684 1084 1106 404 414 87 91 153 165 53 53 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 62 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
267 
disease_progression 
H-positive risk:  684 710 95 1099 414 88 1089 395 171 51 149 55 
H-negative risk:  710 684 1089 1099 395 414 88 95 149 171 55 51 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 63 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
268 
disease_progression 
H-positive risk:  683 708 94 1092 414 87 1089 396 170 56 153 58 
H-negative risk:  708 683 1089 1092 396 414 87 94 153 170 58 56 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 61 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
269 
disease_progression 
H-positive risk:  676 709 93 1093 417 87 1096 390 172 54 151 62 
H-negative risk:  709 676 1096 1093 390 417 87 93 151 172 62 54 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 59 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
270 
disease_progression 
H-positive risk:  676 712 88 1076 420 84 1106 395 175 52 155 61 
H-negative risk:  712 676 1106 1076 395 420 84 88 155 175 61 52 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 61 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
271 
disease_progression 
H-positive risk:  681 707 88 1088 412 86 1102 397 174 54 148 63 
H-negative risk:  707 681 1102 1088 397 412 86 88 148 174 63 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 63 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
272 
disease_progression 
H-positive risk:  689 701 87 1098 408 89 1105 391 173 53 143 63 
H-negative risk:  701 689 1105 1098 391 408 89 87 143 173 63 53 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
273 
disease_progression 
H-positive risk:  693 698 89 1096 411 92 1102 386 174 56 142 61 
H-negative risk:  698 693 1102 1096 386 411 92 89 142 174 61 56 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
274 
disease_progression 
H-positive risk:  702 702 91 1097 408 93 1087 384 178 57 141 60 
H-negative risk:  702 702 1087 1097 384 408 93 91 141 178 60 57 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
275 
disease_progression 
H-positive risk:  705 694 91 1103 403 95 1080 394 177 57 142 59 
H-negative risk:  694 705 1080 1103 394 403 95 91 142 177 59 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
276 
disease_progression 
H-positive risk:  708 698 91 1098 410 87 1081 392 180 58 140 57 
H-negative risk:  698 708 1081 1098 392 410 87 91 140 180 57 58 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 66 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
277 
disease_progression 
H-positive risk:  703 693 88 1099 399 89 1090 400 182 56 144 57 
H-negative risk:  693 703 1090 1099 400 399 89 88 144 182 57 56 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 65 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
278 
disease_progression 
H-positive risk:  709 687 87 1101 396 89 1089 401 184 58 140 59 
H-negative risk:  687 709 1089 1101 401 396 89 87 140 184 59 58 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 66 27 

clinical_engagement 
diagnosis 
demography 
59 new agents 
279 
disease_progression 
H-positive risk:  704 691 85 1097 403 93 1087 398 184 59 140 59 
H-negative risk:  691 704 1087 1097 398 403 93 85 140 184 59 59 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 65 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
280 
disease_progression 
H-positive risk:  699 694 84 1093 402 91 1088 407 178 62 142 60 
H-negative risk:  694 699 1088 1093 407 402 91 84 142 178 60 62 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 63 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
281 
disease_progression 
H-positive risk:  695 687 84 1096 404 87 1099 402 180 62 146 58 
H-negative risk:  687 695 1099 1096 402 404 87 84 146 180 58 62 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 66 25 

clinical_engagement 
diagnosis 
demography 
53 new agents 
282 
disease_progression 
H-positive risk:  694 688 84 1087 405 87 1099 410 181 61 147 57 
H-negative risk:  688 694 1099 1087 410 405 87 84 147 181 57 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
283 
disease_progression 
H-positive risk:  693 683 85 1085 407 88 1101 411 180 62 150 55 
H-negative risk:  683 693 1101 1085 411 407 88 85 150 180 55 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
284 
disease_progression 
H-positive risk:  697 680 86 1076 408 84 1108 414 180 60 150 57 
H-negative risk:  680 697 1108 1076 414 408 84 86 150 180 57 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
285 
disease_progression 
H-positive risk:  702 688 87 1065 413 85 1097 415 178 62 152 56 
H-negative risk:  688 702 1097 1065 415 413 85 87 152 178 56 62 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
286 
disease_progression 
H-positive risk:  700 687 83 1065 416 83 1106 413 177 61 150 59 
H-negative risk:  687 700 1106 1065 413 416 83 83 150 177 59 61 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
287 
disease_progression 
H-positive risk:  697 691 83 1060 417 84 1116 408 176 60 150 58 
H-negative risk:  691 697 1116 1060 408 417 84 83 150 176 58 60 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
288 
disease_progression 
H-positive risk:  699 693 83 1060 416 86 1104 413 175 61 151 59 
H-negative risk:  693 699 1104 1060 413 416 86 83 151 175 59 61 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
289 
disease_progression 
H-positive risk:  702 698 81 1063 415 85 1099 411 173 65 148 60 
H-negative risk:  698 702 1099 1063 411 415 85 81 148 173 60 65 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
290 
disease_progression 
H-positive risk:  701 699 83 1069 410 86 1102 404 174 64 145 63 
H-negative risk:  699 701 1102 1069 404 410 86 83 145 174 63 64 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
291 
disease_progression 
H-positive risk:  698 703 89 1069 401 86 1101 407 173 66 143 64 
H-negative risk:  703 698 1101 1069 407 401 86 89 143 173 64 66 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
292 
disease_progression 
H-positive risk:  697 701 90 1069 405 86 1111 397 172 65 143 64 
H-negative risk:  701 697 1111 1069 397 405 86 90 143 172 64 65 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
293 
disease_progression 
H-positive risk:  694 698 92 1071 413 85 1113 391 175 62 143 63 
H-negative risk:  698 694 1113 1071 391 413 85 92 143 175 63 62 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
294 
disease_progression 
H-positive risk:  688 697 91 1076 414 86 1113 399 169 61 143 63 
H-negative risk:  697 688 1113 1076 399 414 86 91 143 169 63 61 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 68 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
295 
disease_progression 
H-positive risk:  695 699 91 1084 409 88 1111 386 168 62 143 64 
H-negative risk:  699 695 1111 1084 386 409 88 91 143 168 64 62 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
296 
disease_progression 
H-positive risk:  684 701 91 1097 406 88 1113 381 169 63 143 64 
H-negative risk:  701 684 1113 1097 381 406 88 91 143 169 64 63 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
297 
disease_progression 
H-positive risk:  675 690 90 1102 413 88 1122 379 172 63 145 61 
H-negative risk:  690 675 1122 1102 379 413 88 90 145 172 61 63 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
298 
disease_progression 
H-positive risk:  676 696 90 1097 408 86 1115 386 175 64 145 62 
H-negative risk:  696 676 1115 1097 386 408 86 90 145 175 62 64 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
96 new agents 
299 
disease_progression 
H-positive risk:  677 699 92 1100 403 88 1106 389 174 66 147 59 
H-negative risk:  699 677 1106 1100 389 403 88 92 147 174 59 66 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
300 
disease_progression 
H-positive risk:  681 700 92 1087 407 87 1105 398 171 68 146 58 
H-negative risk:  700 681 1105 1087 398 407 87 92 146 171 58 68 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
301 
disease_progression 
H-positive risk:  679 702 90 1072 415 89 1110 402 168 68 146 59 
H-negative risk:  702 679 1110 1072 402 415 89 90 146 168 59 68 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 76 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
302 
disease_progression 
H-positive risk:  679 694 92 1074 413 87 1121 401 168 67 146 58 
H-negative risk:  694 679 1121 1074 401 413 87 92 146 168 58 67 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 77 17 

clinical_engagement 
diagnosis 
demography 
83 new agents 
303 
disease_progression 
H-positive risk:  683 693 93 1069 419 86 1116 407 166 64 146 58 
H-negative risk:  693 683 1116 1069 407 419 86 93 146 166 58 64 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
304 
disease_progression 
H-positive risk:  682 692 97 1071 414 87 1119 411 163 64 142 58 
H-negative risk:  692 682 1119 1071 411 414 87 97 142 163 58 64 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
305 
disease_progression 
H-positive risk:  675 688 94 1067 415 86 1128 413 163 67 146 58 
H-negative risk:  688 675 1128 1067 413 415 86 94 146 163 58 67 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
89 new agents 
306 
disease_progression 
H-positive risk:  680 690 95 1064 414 87 1127 410 158 67 150 58 
H-negative risk:  690 680 1127 1064 410 414 87 95 150 158 58 67 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
307 
disease_progression 
H-positive risk:  672 690 92 1063 411 89 1127 419 155 70 151 61 
H-negative risk:  690 672 1127 1063 419 411 89 92 151 155 61 70 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 76 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
308 
disease_progression 
H-positive risk:  669 690 94 1055 411 89 1128 418 156 70 156 64 
H-negative risk:  690 669 1128 1055 418 411 89 94 156 156 64 70 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 77 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
309 
disease_progression 
H-positive risk:  673 687 90 1052 416 89 1130 413 157 72 158 63 
H-negative risk:  687 673 1130 1052 413 416 89 90 158 157 63 72 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 77 17 

clinical_engagement 
diagnosis 
demography 
92 new agents 
310 
disease_progression 
H-positive risk:  676 680 89 1054 424 89 1134 407 154 76 155 62 
H-negative risk:  680 676 1134 1054 407 424 89 89 155 154 62 76 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 77 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
311 
disease_progression 
H-positive risk:  681 680 90 1061 417 89 1130 409 155 73 152 63 
H-negative risk:  680 681 1130 1061 409 417 89 90 152 155 63 73 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 77 16 

clinical_engagement 
diagnosis 
demography 
81 new agents 
312 
disease_progression 
H-positive risk:  678 688 88 1062 411 90 1139 406 150 73 151 64 
H-negative risk:  688 678 1139 1062 406 411 90 88 151 150 64 73 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 76 16 

clinical_engagement 
diagnosis 
demography 
59 new agents 
313 
disease_progression 
H-positive risk:  673 679 87 1070 413 93 1134 410 151 72 154 64 
H-negative risk:  679 673 1134 1070 410 413 93 87 154 151 64 72 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 74 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
314 
disease_progression 
H-positive risk:  667 689 90 1069 419 91 1130 410 149 72 151 63 
H-negative risk:  689 667 1130 1069 410 419 91 90 151 149 63 72 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 73 17 

clinical_engagement 
diagnosis 
demography 
60 new agents 
315 
disease_progression 
H-positive risk:  664 681 89 1077 422 89 1136 404 148 74 151 65 
H-negative risk:  681 664 1136 1077 404 422 89 89 151 148 65 74 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 76 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
316 
disease_progression 
H-positive risk:  661 677 89 1077 422 90 1146 403 146 75 147 67 
H-negative risk:  677 661 1146 1077 403 422 90 89 147 146 67 75 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 77 16 

clinical_engagement 
diagnosis 
demography 
81 new agents 
317 
disease_progression 
H-positive risk:  669 681 91 1073 414 90 1144 407 146 74 145 66 
H-negative risk:  681 669 1144 1073 407 414 90 91 145 146 66 74 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 79 15 

clinical_engagement 
diagnosis 
demography 
76 new agents 
318 
disease_progression 
H-positive risk:  665 683 91 1073 412 94 1148 410 140 74 143 67 
H-negative risk:  683 665 1148 1073 410 412 94 91 143 140 67 74 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 78 15 

clinical_engagement 
diagnosis 
demography 
88 new agents 
319 
disease_progression 
H-positive risk:  666 683 94 1066 403 93 1153 417 141 75 142 67 
H-negative risk:  683 666 1153 1066 417 403 93 94 142 141 67 75 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 78 15 

clinical_engagement 
diagnosis 
demography 
62 new agents 
320 
disease_progression 
H-positive risk:  659 680 96 1079 401 91 1165 404 145 75 138 67 
H-negative risk:  680 659 1165 1079 404 401 91 96 138 145 67 75 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 77 14 

clinical_engagement 
diagnosis 
demography 
67 new agents 
321 
disease_progression 
H-positive risk:  656 677 97 1083 408 92 1162 403 143 75 138 66 
H-negative risk:  677 656 1162 1083 403 408 92 97 138 143 66 75 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 80 14 

clinical_engagement 
diagnosis 
demography 
83 new agents 
322 
disease_progression 
H-positive risk:  647 684 100 1084 394 93 1168 406 142 76 137 69 
H-negative risk:  684 647 1168 1084 406 394 93 100 137 142 69 76 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
323 
disease_progression 
H-positive risk:  658 682 103 1084 394 95 1154 415 139 70 139 67 
H-negative risk:  682 658 1154 1084 415 394 95 103 139 139 67 70 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
94 new agents 
324 
disease_progression 
H-positive risk:  671 673 104 1086 397 97 1149 409 135 72 135 72 
H-negative risk:  673 671 1149 1086 409 397 97 104 135 135 72 72 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
79 new agents 
325 
disease_progression 
H-positive risk:  668 688 105 1080 398 96 1146 406 133 72 135 73 
H-negative risk:  688 668 1146 1080 406 398 96 105 135 133 73 72 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
103 new agents 
326 
disease_progression 
H-positive risk:  674 686 109 1080 400 95 1134 408 137 68 135 74 
H-negative risk:  686 674 1134 1080 408 400 95 109 135 137 74 68 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
82 new agents 
327 
disease_progression 
H-positive risk:  667 684 105 1083 395 93 1140 418 136 68 137 74 
H-negative risk:  684 667 1140 1083 418 395 93 105 137 136 74 68 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 86 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
328 
disease_progression 
H-positive risk:  667 692 105 1080 395 95 1137 417 134 69 137 72 
H-negative risk:  692 667 1137 1080 417 395 95 105 137 134 72 69 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 85 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
329 
disease_progression 
H-positive risk:  661 701 101 1086 392 98 1126 427 134 64 143 67 
H-negative risk:  701 661 1126 1086 427 392 98 101 143 134 67 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
88 new agents 
330 
disease_progression 
H-positive risk:  666 694 106 1094 392 97 1122 424 134 64 142 65 
H-negative risk:  694 666 1122 1094 424 392 97 106 142 134 65 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 88 17 

clinical_engagement 
diagnosis 
demography 
77 new agents 
331 
disease_progression 
H-positive risk:  663 702 106 1090 390 97 1133 419 135 60 140 65 
H-negative risk:  702 663 1133 1090 419 390 97 106 140 135 65 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
332 
disease_progression 
H-positive risk:  663 702 104 1095 399 97 1130 417 129 60 142 62 
H-negative risk:  702 663 1130 1095 417 399 97 104 142 129 62 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
333 
disease_progression 
H-positive risk:  661 706 103 1088 400 97 1136 421 129 58 139 62 
H-negative risk:  706 661 1136 1088 421 400 97 103 139 129 62 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
334 
disease_progression 
H-positive risk:  667 709 101 1087 397 97 1130 421 133 58 138 62 
H-negative risk:  709 667 1130 1087 421 397 97 101 138 133 62 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
335 
disease_progression 
H-positive risk:  668 706 103 1090 400 94 1119 430 137 55 139 59 
H-negative risk:  706 668 1119 1090 430 400 94 103 139 137 59 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
336 
disease_progression 
H-positive risk:  674 705 104 1092 398 90 1112 434 132 57 142 60 
H-negative risk:  705 674 1112 1092 434 398 90 104 142 132 60 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
337 
disease_progression 
H-positive risk:  679 700 104 1097 405 89 1101 430 135 56 145 59 
H-negative risk:  700 679 1101 1097 430 405 89 104 145 135 59 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
338 
disease_progression 
H-positive risk:  674 690 102 1103 403 92 1108 426 133 59 150 60 
H-negative risk:  690 674 1108 1103 426 403 92 102 150 133 60 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
339 
disease_progression 
H-positive risk:  673 698 102 1085 407 94 1103 431 136 60 152 59 
H-negative risk:  698 673 1103 1085 431 407 94 102 152 136 59 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
340 
disease_progression 
H-positive risk:  674 695 100 1097 401 95 1107 427 134 60 152 58 
H-negative risk:  695 674 1107 1097 427 401 95 100 152 134 58 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
341 
disease_progression 
H-positive risk:  679 694 101 1100 400 96 1100 430 131 60 150 59 
H-negative risk:  694 679 1100 1100 430 400 96 101 150 131 59 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
342 
disease_progression 
H-positive risk:  678 698 102 1104 404 99 1090 424 128 62 151 60 
H-negative risk:  698 678 1090 1104 424 404 99 102 151 128 60 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
343 
disease_progression 
H-positive risk:  672 702 102 1102 405 99 1094 423 133 59 149 60 
H-negative risk:  702 672 1094 1102 423 405 99 102 149 133 60 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
344 
disease_progression 
H-positive risk:  672 710 100 1105 399 99 1088 421 135 59 151 61 
H-negative risk:  710 672 1088 1105 421 399 99 100 151 135 61 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
345 
disease_progression 
H-positive risk:  668 712 100 1113 394 102 1083 427 134 56 151 60 
H-negative risk:  712 668 1083 1113 427 394 102 100 151 134 60 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
346 
disease_progression 
H-positive risk:  667 711 96 1117 391 101 1088 422 136 57 152 62 
H-negative risk:  711 667 1088 1117 422 391 101 96 152 136 62 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
347 
disease_progression 
H-positive risk:  670 713 93 1114 390 99 1089 421 136 60 155 60 
H-negative risk:  713 670 1089 1114 421 390 99 93 155 136 60 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
96 new agents 
348 
disease_progression 
H-positive risk:  670 712 94 1111 394 98 1087 418 140 58 158 60 
H-negative risk:  712 670 1087 1111 418 394 98 94 158 140 60 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
349 
disease_progression 
H-positive risk:  670 723 95 1094 397 96 1092 418 141 58 155 61 
H-negative risk:  723 670 1092 1094 418 397 96 95 155 141 61 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
350 
disease_progression 
H-positive risk:  673 726 94 1090 393 94 1095 421 143 53 157 61 
H-negative risk:  726 673 1095 1090 421 393 94 94 157 143 61 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
64 new agents 
351 
disease_progression 
H-positive risk:  677 728 91 1090 394 95 1093 417 144 51 158 62 
H-negative risk:  728 677 1093 1090 417 394 95 91 158 144 62 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 70 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
352 
disease_progression 
H-positive risk:  668 725 89 1095 393 94 1104 411 146 52 158 65 
H-negative risk:  725 668 1104 1095 411 393 94 89 158 146 65 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
353 
disease_progression 
H-positive risk:  657 719 88 1101 395 94 1112 412 148 51 160 63 
H-negative risk:  719 657 1112 1101 412 395 94 88 160 148 63 51 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 67 27 

clinical_engagement 
diagnosis 
demography 
57 new agents 
354 
disease_progression 
H-positive risk:  656 714 89 1105 395 92 1116 413 150 52 153 65 
H-negative risk:  714 656 1116 1105 413 395 92 89 153 150 65 52 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 67 26 

clinical_engagement 
diagnosis 
demography 
86 new agents 
355 
disease_progression 
H-positive risk:  663 716 89 1103 396 92 1106 417 150 51 153 64 
H-negative risk:  716 663 1106 1103 417 396 92 89 153 150 64 51 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
356 
disease_progression 
H-positive risk:  654 715 89 1112 384 92 1118 414 151 54 152 65 
H-negative risk:  715 654 1118 1112 414 384 92 89 152 151 65 54 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 67 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
357 
disease_progression 
H-positive risk:  651 716 90 1112 386 91 1107 417 154 54 151 71 
H-negative risk:  716 651 1107 1112 417 386 91 90 151 154 71 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
60 new agents 
358 
disease_progression 
H-positive risk:  655 717 88 1105 385 91 1113 416 157 53 148 72 
H-negative risk:  717 655 1113 1105 416 385 91 88 148 157 72 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 73 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
359 
disease_progression 
H-positive risk:  653 715 87 1101 394 91 1113 416 161 53 147 69 
H-negative risk:  715 653 1113 1101 416 394 91 87 147 161 69 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 72 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
360 
disease_progression 
H-positive risk:  654 712 88 1100 395 92 1111 416 165 51 146 70 
H-negative risk:  712 654 1111 1100 416 395 92 88 146 165 70 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 74 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
Time difference of 18.27321 mins
This is task 10
date
